BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 31626938)

  • 1. Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers (ACEI/ARB) are Associated with Improved Limb Salvage after Infrapopliteal Interventions for Critical Limb Ischemia.
    Khan SZ; Montross B; Rivero M; Cherr GS; Harris LM; Dryjski ML; Dosluoglu HH
    Ann Vasc Surg; 2020 Feb; 63():275-286. PubMed ID: 31626938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
    Veraldi GF; Mezzetto L; Macrì M; Criscenti P; Corvasce A; Poli R
    Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous Superficial Femoral Artery Angioplasty/Stent Plus Popliteal Distal Bypass for Limb Salvage.
    Barillà D; Spinelli D; Stilo F; Derone G; Pipitò N; Spinelli F; Benedetto F
    Ann Vasc Surg; 2020 Feb; 63():443-449. PubMed ID: 31669474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endovascular Therapy Provides Similar Results of Bypass Graft Surgery in the Treatment of Infrainguinal Multilevel Arterial Disease in Patients with Chronic Limb-Threatening Ischemia in All GLASS Stages.
    Casella IB; Sartori CH; Faustino CB; Vieira Mariz MP; Presti C; Puech-Leão P; De Luccia N
    Ann Vasc Surg; 2020 Oct; 68():400-408. PubMed ID: 32339688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin converting enzyme inhibitors and angiotensin receptor blockers have no effect on the outcomes of endovascular revascularization in tibial arterial occlusive disease.
    Juneja A; Zia S; Abeysekara A; Shams S; Singh K; Schor J; Deitch J
    Vascul Pharmacol; 2020 Aug; 131():106764. PubMed ID: 32629143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of patients with diabetes mellitus undergoing percutaneous intervention for popliteal and infrapopliteal peripheral arterial disease.
    Neupane S; Edla S; Maidona E; Sweet MC; Szpunar S; Davis T; LaLonde TA; Mehta RH; Rosman HS; Yamasaki H
    Catheter Cardiovasc Interv; 2018 Jul; 92(1):117-123. PubMed ID: 29536612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitinol Stent Versus Bypass in Long Femoropopliteal Lesions: 2-Year Results of a Randomized Controlled Trial.
    Enzmann FK; Nierlich P; Aspalter M; Hitzl W; Dabernig W; Hölzenbein T; Ugurluoglu A; Seitelberger R; Linni K
    JACC Cardiovasc Interv; 2019 Dec; 12(24):2541-2549. PubMed ID: 31786218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of primary stent therapy for femoropopliteal peripheral arterial disease at 7 years.
    Stavroulakis K; Torsello G; Manal A; Schwindt A; Hericks C; Stachmann A; Schönefeld E; Bisdas T
    J Vasc Surg; 2016 Dec; 64(6):1696-1702. PubMed ID: 27575816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of infrapopliteal endovascular treatment on the outcome of subsequent ipsilateral distal bypass for critical limb ischemia.
    Tsuji Y; Shiraki T; Iida O; Tsuji Y; Kitano I; Sugimoto K; Okita Y
    J Cardiovasc Surg (Torino); 2017 Dec; 58(6):828-834. PubMed ID: 26397712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin Is Associated with Improved Survival and Decreased Cardiac Events with No Impact on Patency and Limb Salvage after Revascularization for Peripheral Arterial Disease.
    Khan SZ; Rivero M; Nader ND; Cherr GS; Harris LM; Dryjski ML; Dosluoglu HH
    Ann Vasc Surg; 2019 Feb; 55():63-77. PubMed ID: 30081159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iliac Artery Stenting Combined with Ipsilateral Open Femoro-Popliteal Revascularization and Its Effect on Bypass Patency.
    Piazza M; Squizzato F; Lepidi S; Menegolo M; Grego F; Antonello M
    Ann Vasc Surg; 2017 Oct; 44():282-288. PubMed ID: 28479462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex infrapopliteal revascularization in elderly patients with critical limb ischemia: impact of multidisciplinary integrated care on mid-term outcome.
    Biasi L; Patel SD; Lea T; Donati T; Katsanos K; Partridge JS; Dhesi JK; Zayed H
    J Cardiovasc Surg (Torino); 2017 Oct; 58(5):665-673. PubMed ID: 27195520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major adverse limb events and wound healing following infrapopliteal artery stent implantation in patients with critical limb ischemia: the XCELL trial.
    Rocha-Singh KJ; Jaff M; Joye J; Laird J; Ansel G; Schneider P;
    Catheter Cardiovasc Interv; 2012 Nov; 80(6):1042-51. PubMed ID: 22605682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-coated balloon angioplasty for the management of recurring infrapopliteal disease in diabetic patients with critical limb ischemia.
    Palena LM; Diaz-Sandoval LJ; Gomez-Jaballera E; Peypoch-Perez O; Sultato E; Brigato C; Brocco E; Manzi M
    Cardiovasc Revasc Med; 2018; 19(1 Pt B):83-87. PubMed ID: 28648324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comparison of Contemporary Clinical Outcomes Following Femoro-Popliteal Plain Balloon Angioplasty and Bypass Surgery for Chronic Limb Threatening Ischemia.
    Meecham L; Popplewell MA; Bate GR; Patel S; Bradbury AW
    Vasc Endovascular Surg; 2021 Aug; 55(6):544-550. PubMed ID: 33882737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bifurcated coronary stents for infrapopliteal angioplasty in critical limb ischemia.
    Silingardi R; Tasselli S; Cataldi V; Moratto R; Gennai S; Coppi G; Marcheselli L; Coppi G
    J Vasc Surg; 2013 Apr; 57(4):1006-13. PubMed ID: 23343667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Limb Salvage and Amputation-Free Survival After Femoropopliteal Bypass and Femoropopliteal PTA for Critical Ischemia in a Clinical Cohort.
    Altreuther M; Mattsson E
    Vasc Endovascular Surg; 2019 Feb; 53(2):112-117. PubMed ID: 30803415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Number of infrapopliteal arteries undergoing endovascular treatment is not associated with the limb salvage rate in patients with critical limb ischemia.
    de Athayde Soares R; Matielo MF; Brochado Neto FC; Martins Cury MV; Marques RC; Sacilotto R
    J Vasc Surg; 2016 Nov; 64(5):1344-1350. PubMed ID: 27288107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.
    Almasri J; Adusumalli J; Asi N; Lakis S; Alsawas M; Prokop LJ; Bradbury A; Kolh P; Conte MS; Murad MH
    J Vasc Surg; 2019 Jun; 69(6S):126S-136S. PubMed ID: 31159976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved survival with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic limb-threatening ischemia.
    Khan SZ; O'Brien-Irr MS; Rivero M; Blochle R; Cherr GS; Dryjski ML; Dosluoglu HH; Lukan J; Rowe VL; Harris LM
    J Vasc Surg; 2020 Dec; 72(6):2130-2138. PubMed ID: 32276021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.